Exceptionally Long Recurrence‐Free Survival in a Male Patient With Fibrolamellar Hepatocellular Carcinoma
Open Access
- 1 January 2026
- journal article
- case report
- Published by Wiley in Case Reports in Hepatology
- Vol. 2026 (1)
Abstract
Fibrolamellar hepatocellular carcinoma (FLHCC) accounts for less than 1% of all primary liver cancers. Due to an absence of known risk factors, most individuals are diagnosed at advanced stages of disease. Subsequently, these tumors carry a 30%–50% mortality rate and a 33%–100% recurrence rate in those treated with curative intent. Here, we describe an incidental discovery of an FLHCC tumor in a young male patient, who following surgical resection has remained recurrence free for over 11 years. This exceptionally long recurrence‐free survival highlights the advantage of early‐stage detection, the benefit of complete tumor resection, and further underscores the importance of regular postresection cancer surveillance.Keywords
This publication has 26 references indexed in Scilit:
- A Case of Fibrolamellar Cancer With a Palliative Response and Minor Radiographic Regression With Erlotinib and Bevacizumab Combination TherapyAmerican Journal of Therapeutics, 2014
- Clinicopathologic characteristics and survival outcomes of patients with fibrolamellar carcinoma: data from the fibrolamellar carcinoma consortium.2013
- A Systematic Review: Treatment and Prognosis of Patients with Fibrolamellar Hepatocellular CarcinomaJournal of the American College of Surgeons, 2012
- Prolonged Complete Response after GEMOX Chemotherapy in a Patient with Advanced Fibrolamellar Hepatocellular CarcinomaCase Reports in Oncology, 2012
- Fibrolamellar carcinomas are positive for CD68Laboratory Investigation, 2010
- Fibrolamellar hepatocellular carcinoma – Prolonged survival with multimodality therapyEuropean Journal of Surgical Oncology, 2009
- Outcome of patients with fibrolamellar hepatocellular carcinomaCancer, 2006
- Clinical and pathologic factors associated with survival in young adult patients with fibrolamellar hepatocarcinomaBMC Cancer, 2005
- Is fibrolamellar carcinoma different from hepatocellular carcinoma? A US population-based studyHepatology, 2004
- Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinomaTransplant International, 2000